- Report
- May 2025
- 191 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- February 2025
- 240 Pages
Global
From €2437EUR$2,690USD£2,100GBP
- Report
- June 2025
- 147 Pages
Global
From €4439EUR$4,900USD£3,826GBP
- Report
- April 2025
Global
From €4439EUR$4,900USD£3,826GBP
- Report
- April 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- April 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- January 2025
- 175 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- July 2025
- 367 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 483 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 276 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- May 2025
- 173 Pages
Global
From €4077EUR$4,500USD£3,514GBP
- Report
- January 2025
- 135 Pages
Global
From €2717EUR$2,999USD£2,342GBP
- Clinical Trials
- July 2025
- 180 Pages
Global
From €2265EUR$2,500USD£1,952GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1359EUR$1,500USD£1,171GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1132EUR$1,250USD£976GBP
- Report
- October 2024
- 210 Pages
Global
From €7202EUR$7,950USD£6,208GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,864GBP
- Report
- October 2024
- 250 Pages
Global
From €4483EUR$4,949USD£3,864GBP

Phenytoin is a cardiovascular drug used to treat arrhythmias, or irregular heartbeats. It is also used to prevent seizures in people with epilepsy. Phenytoin works by slowing down the electrical signals in the brain that cause seizures. It is available in both generic and brand-name forms. The drug is available in both oral and intravenous forms.
Phenytoin is used to treat a variety of cardiovascular conditions, including atrial fibrillation, ventricular tachycardia, and Wolff-Parkinson-White syndrome. It is also used to prevent seizures in people with epilepsy. The drug is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and nausea.
The phenytoin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Mylan. Show Less Read more